 Detection proliferation rate breast cancer Correlation clinical pathologic features situ determination proliferative activity breast cancers use monoclonal antibody immunohistochemical methods Tumor proliferation rate size nodal status relationship proliferative activity nuclear estrogen receptor content adjacent tissue sections values median value Premenopausal patients values median value postmenopausal ones median value authors correlation lymph nodal involvement significant relationship tumor size inverse correlation Spearman coefficient values nuclear estrogen receptor content results similar kinetic measurements situ detection proliferation rate useful method cell cycle information Follow-up studies eventual prognostic relevance